A. Bertini

Real-world overall survival improvements in metastatic urothelial carcinoma across three key therapeutic temporal periods

Background Over the past decades, treatment of metastatic urothelial carcinoma (mUC) has been transformed by three backbone therapies: platinum-based chemotherapy (PBC), immune checkpoint inhibitors (ICIs), and antibody-drug conjugates (ADCs), used alone or in combination. Evaluating temporal trends in overall survival...

Positive surgical margins after partial nephrectomy across changing surgical eras: long-term oncological results from a tertiary referral center

Patient-Reported Complications and Outcomes of General, Central Neuraxial, and Peripheral Regional Anesthesia in Charcot-Marie-Tooth Disease.

Anesthesia-related complications are not reported more frequently in patients with CMT compared with controls, however, longitudinal studies incorporating objective clinical assessments and detailed information on anesthetic agents are warranted.